 comparison cyclophosphamid doxorubicin vincristin regimen methotrex cisplatin/cyclophosphamid doxorubicin vincristin treatment extensive-diseas small-cel lung carcinoma mid-atlant oncolog program studi regimen treatment extensive-diseas small-cel lung cancer sclc standard treatment cyclophosphamid doxorubicin vincristin cav patient overal sever toxic similar arm toxic death arm respons result similar complet partial respons standard regimen complet partial respons regimen median surviv time month standard regimen month regimen surviv rate standard regimen regimen surviv benefit treatment regimen statist signific subset patient prognosi male sex perform statu liver metastas bone marrow metastas oat cell histolog subtyp